Cellular Intelligence offers a platform that combines synthetic biology with computational design to create programmable cellular systems. Their workflow lets biotech and pharma companies model, synthesize, and test custom genetic circuits and pathways, reducing development time and variability for therapeutics, diagnostics, and industrial bioproducts.
Funding
Funding not disclosed
Founders
Product
Problem
Biological processes are inherently variable and difficult to control, limiting the reliability and speed of developing therapeutics, diagnostics, and industrial bioproducts.
Solution
Cellular Intelligence combines synthetic biology with computational design to engineer programmable biological systems that precisely modulate cellular functions. Their platform enables the creation of custom bio‑components tailored to specific therapeutic, diagnostic, or manufacturing needs, shortening development cycles and minimizing dependence on natural biological variability. By providing a design‑to‑implementation workflow, they allow users to model, synthesize, and test engineered cells in a streamlined, reproducible manner.
Target Audience
Primary customers are biotech firms, pharmaceutical developers, and industrial biotechnology companies seeking reliable, customizable cellular engineering solutions.
Features
- Integrated computational design tools for rapid in silico modeling of genetic circuits and pathways
- Automated DNA synthesis and assembly pipelines that translate designs into functional bio‑components
- Standardized modular parts library enabling plug‑and‑play construction of custom cellular functions
- High‑throughput screening workflows to validate engineered cells and iterate designs quickly
- Compatibility with therapeutic, diagnostic, and industrial cell platforms for diverse applications